KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $639,000 | -12.8% | 187,900 | -3.6% | 0.00% | -20.0% |
| Q2 2018 | $733,000 | -4.7% | 194,900 | +3.6% | 0.01% | 0.0% |
| Q1 2018 | $769,000 | -12.1% | 188,100 | 0.0% | 0.01% | -16.7% |
| Q4 2017 | $875,000 | -35.9% | 188,100 | -2.2% | 0.01% | -40.0% |
| Q3 2017 | $1,366,000 | +33.8% | 192,400 | +36.3% | 0.01% | +25.0% |
| Q2 2017 | $1,021,000 | +703.9% | 141,200 | +1468.9% | 0.01% | – |
| Q4 2014 | $127,000 | +33.7% | 9,000 | +21.6% | 0.00% | – |
| Q4 2013 | $95,000 | +31.9% | 7,400 | +2.8% | 0.00% | – |
| Q3 2013 | $72,000 | – | 7,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 700,273 | $10,770,000 | 5.76% |
| HARVEY CAPITAL MANAGEMENT INC | 932,400 | $14,340,000 | 5.13% |
| Camber Capital Management LP | 3,000,000 | $46,140,000 | 3.02% |
| Baupost Group | 10,539,986 | $162,105,000 | 2.64% |
| SECTORAL ASSET MANAGEMENT INC | 3,741,656 | $57,547,000 | 2.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,884,409 | $59,742,000 | 2.40% |
| Knoll Capital Management, LLC | 200,000 | $3,076,000 | 1.37% |
| DAFNA Capital Management LLC | 92,400 | $1,421,000 | 1.35% |
| NORTHPOINTE CAPITAL LLC | 892,011 | $13,719,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 240,000 | $3,691,000 | 1.10% |